Finance

Lists
CYP:ASX
Cynata Therapeutics Ltd
A$0.011
0.00%
(0.00) 1D
Sep 4, 4:00:00 PM GMT+10  ·   AUD
All symbols
SymbolPriceChange% Change
Generating top insights for CYP...
Open
A$0.01
High
A$0.01
Low
A$0.01
Mkt. cap
2.95M
Avg. vol.
452.12K
Volume
604.53K
52-wk high
A$0.44
52-wk low
A$0.01
EPS
-A$0.04
Shares outstanding
243.45M
No. of employees
0
Open
A$0.01
High
A$0.01
Low
A$0.01
Mkt. cap
2.95M
Avg. vol.
452.12K
Volume
604.53K
52-wk high
A$0.44
52-wk low
A$0.01
EPS
-A$0.04
Shares outstanding
243.45M
No. of employees
0
About Cynata Therapeutics Ltd
CEORoss Alexander Macdonald
Employees0
Founded2003
Headquarters-
SectorBiotechnology
Websitecynata.com
Previous reportsAll values in AUD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in AUD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
886.14K
886.14K
9.42K
9.42K
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
2.69M
2.69M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.69M
1.69M
-763.69K
-763.69K
Operating expense
2.22M
2.22M
2.55M
2.55M
Total operating expenses
2.22M
2.22M
2.55M
2.55M
Operating income
-1.33M
-1.33M
-2.54M
-2.54M
Other non operating income
-
-
-
-
EBT including unusual items
-1.33M
-1.33M
-3.21M
-3.21M
EBT excluding unusual items
-1.33M
-1.33M
-2.54M
-2.54M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
425.31K
425.31K
528.16K
528.16K
Net income
-1.33M
-1.33M
-3.21M
-3.21M
Net profit margin
-150.23%
-150.23%
-34,130.88%
-34,130.88%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-1.27M
-1.27M
-2.47M
-2.47M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps